INTRODUCTION {#s1}
============

Biliary tract cancer (BTC) is a category of tumors that includes gallbladder cancer (GBC), cholangiocarcinoma, and ampullary cancer \[[@R1], [@R2]\]. Although BTC is rare, its incidence is increasing worldwide \[[@R3], [@R4]\]. In Japan, BTC is the sixth leading cause of cancer-related death, and more than 18,000 patients die from the disease annually \[[@R5]\]. Radical resection remains the only curative treatment for BTC, and recurrence rates after resection are high \[[@R6], [@R7]\]. Moreover, because BTC is usually diagnosed at an advanced stage, most patients are not considered candidates for curative resection. Despite recent improvements in surgical techniques and adjuvant therapy, the overall prognosis of BTC remains poor \[[@R8], [@R9]\]. It is therefore vital to identify factors that predict prognosis in BTC patients to help clinicians implement better therapeutic strategies.

Studies have identified a positive correlation between marital status and survival in BTC patients, and married people are healthier overall and live longer than unmarried people (divorced, separated, never married) \[[@R10]--[@R12]\]. In a large study of multiple cancer treatment sites, married patients were more likely to present with early stage disease upon diagnosis and to receive definitive treatment compared to unmarried patients \[[@R13]\]. Being married is also positively associated with overall and cancer-related survival for various types of cancer, such as hepatocellular carcinoma \[[@R14]\], breast cancer \[[@R15]\], gastric adenocarcinoma \[[@R16]\], and pancreatic cancer \[[@R17]\]. According to a larger-scale population-based study of information from the Surveillance, Epidemiology, and End Results (SEER) database, unmarried patients are at significantly higher risk of presentation with metastatic cancer, undertreatment, and cancer-related death \[[@R13]\]. However, little is known about the association between marital status and BTC. In this study, we investigated the association between marital status and cause-specific survival (CSS) in BTC patients by examining data from the Surveillance, Epidemiology, and End Results (SEER) cancer registry program for individuals diagnosed between 2004 and 2014.

MATERIALS AND METHODS {#s2}
=====================

Patient population and study design {#s2_1}
-----------------------------------

The Surveillance, Epidemiology, and End Results (SEER) Program of the US National Cancer Institute (NCI) was used as the data source for this population-based investigation. The SEER Program captures approximately 97% of incident cancers, and the 17 SEER tumor registries encompass approximately 28% of the US population \[[@R18]\]. The SEER Program collects information on cancer incidence, prevalence, survival, and cancer patient mortality.

We used the SEER Program to identify 24035 patients who were diagnosed with biliary tract cancer between 2004 and 2014. Patients with a diagnosis of biliary tract cancer (International Classification of Diseases for Oncology, Third Edition \[ICD-O-3\], histology codes 8010, 8020, 8040, 8041, 8070, 8140, 8144, 8160, 8161, 8162, 8260, 8310, 8480, 8490, and 8560, and site codes C23.0, C23.9, C22.1, C24.0, and C24.1) were considered for analysis. Patients more than 18 years old for whom marital status, cause of death, and survival duration in months were known were included in the current study. Patients with multiple primary cancers were excluded if BTC was not the first disease diagnosed.

This study was based on public data from the SEER database; we obtained permission to access research data files (reference number 10091-Nov 2016). The data did not include the use of human subjects or personal identifying information; thus, informed consent was not required.

Study variables {#s2_2}
---------------

Several variables, including demographics (sex, age, race), TNM stage, extent of disease (localized, regional, distant), tumor site (gallbladder cancer and cholangiocarcinoma, ampulla of Vater cancer), tumor grade (well-differentiated, moderately differentiated, poorly differentiated, undifferentiated, unknown), histologic type, treatment, and marital status at the time of diagnosis were examined. Marital status, the major variable of interest, was classified in a binary manner (married vs unmarried). The unmarried category included widowed and separated/divorced patients as well as those who never married. The AJCC 6th TNM staging system was used; because this staging system became publicly available in 2004, we restricted our study to patients diagnosed from 2004--2014. According to the SEER staging system, tumors that remain *in situ*, or confined to the organ of origin, were considered localized. Those with local invasion or metastasis to regional lymph nodes were categorized as regional, while those with cancer that traveled to distant organs were categorized as distant.

Statistical analyses {#s2_3}
--------------------

Baseline patient demographics and disease characteristics were compared using *t*-tests or chi-square tests as appropriate. The Kaplan-Meier method was used to assess survival functions. The log rank test was used to test differences between survival curves. Cox proportional hazards multivariable regression was used to assess the impact of marital status on cancer-specific mortality. The primary outcomes of interest in this study was 5-year CSS, which was calculated from the date of diagnosis to the date of cancer-specific death. Deaths attributed to BTC were treated as events, while deaths from other causes were treated as censored observations. All *P* values were 2-sided, and *P* values \< 0.05 were considered statistically significant. All statistical analyses were performed using SPSS version 23 (Statistics Package for Social Science, Chicago, IL).

RESULTS {#s3}
=======

Patient characteristics {#s3_1}
-----------------------

A total of 24035 qualified patients who were diagnosed during the 10-year study period (2004 to 2014) were identified. Of these patients, 10774 (44.8%) were male and 13261 (55.2%) were female. 13268 (55.2%) were married, 5062 (21.1%) were widowed, 3347 (13.9%) had never married, and 2358 (9.8%) were divorced or separated. Higher proportions of patients in the widowed group were women, elderly (\> 60 years), had gallbladder cancer, and had more localized SEER Stage disease compared to all other patients (all *p* \< 0.001). Patient demographics and pathological features are shown in Table [1](#T1){ref-type="table"}.

###### Baseline demographic and tumor characteristics of SEER database patients

  --------------------------------------------------------------------------------------------------
                       Total   Married        Widowed       Never married   Divorced/\    *P*
                                                                            Separated     
  -------------------- ------- -------------- ------------- --------------- ------------- ----------
  Sex                                                                                     \< 0.001

   Male                10774   7396 (55.7)    898 (17.7)    1530 (45.7)     950 (40.3)    

   Female              13261   5872 (44.3)    4164 (82.3)   1817 (54.3)     1408 (59.7)   

  Age                                                                                     \< 0.001

   ≤ 60                6314    3866 (29.1)    210 (4.1)     1452 (43.4)     786 (33.3)    

   \> 60               17721   9402 (70.9)    4852 (95.9)   1895 (56.6)     1572 (66.7)   

  Race                                                                                    \< 0.001

   White               18478   10302 (77.6)   3935 (76.4)   2405 (73.8)     1836 (77.9)   

   Black               2270    886 (6.7)      579 (11.2)    489 (15.0)      316 (13.4)    

   Other^\*^           3287    2080 (15.7)    638 (12.4)    363 (11.1)      206 (8.7)     

  Tumor site                                                                              \< 0.001

   Gallbladder         7869    4014 (30.3)    1938 (38.3)   1120 (33.5)     797 (33.8)    

   Bile duct           12668   7176 (54.1)    2503 (49.4)   1748 (52.2)     1241 (52.6)   

   Ampulla of Vater    3498    2078 (15.7)    621 (12.3)    479 (14.3)      320 (13.6)    

  AJCC 6th TNM stage                                                                      \< 0.001

   I                   5205    2842 (22.2)    1224 (22.0)   675 (20.2)      464 (19.7)    

   II                  5109    2974 (23.3)    938 (16.9)    690 (20.6)      507 (21.5)    

   III                 2715    1627 (12.7)    432 (7.8)     356 (10.6)      300 (12.7)    

   IV                  7521    4239 (33.2)    1373 (24.7)   1117 (33.4)     792 (33.6)    

   Unknown             3485    1095 (8.6)     1586 (28.6)   509 (15.2)      295 (12.5)    

  Grade                                                                                   \< 0.001

   I                   1702    985 (7.4)      334 (6.6)     237 (7.1)       146 (6.2)     

   II                  5891    3443 (25.9)    1059 (20.9)   819 (24.5)      570 (24.2)    

   III                 5139    3006 (22.7)    943 (18.6)    682 (20.4)      508 (21.5)    

   IV                  220     125 (0.9)      52 (1.0)      26 (0.8)        17 (0.7)      

   Unknown             11083   5709 (43.0)    2674 (52.8)   1583 (47.3)     1117 (47.4)   

  SEER Stage                                                                              \< 0.001

   Localized           5526    2870 (21.6)    1390 (27.5)   757 (22.6)      509 (21.6)    

   Regional            7853    4680 (35.3)    1370 (27.1)   1051 (31.4)     752 (31.9)    

   Distant             8367    4743 (35.7)    1504 (29.7)   1227 (36.7)     893 (37.9)    

   Unknown             2289    975 (7.3)      798 (15.8)    312 (9.3)       204 (8.7)     

  Therapy                                                                                 \< 0.001

   Surgery             10169   6046 (45.6)    1788 (35.3)   1353 (40.4)     982 (41.6)    

   No surgery          13629   7107 (53.6)    3207 (63.4)   1962 (58.6)     1353 (57.4)   

   Unknown             237     115 (0.9)      67 (1.3)      32 (1.0)        23 (1.0)      
  --------------------------------------------------------------------------------------------------

^\*^: Other includes American Indian/Alaska native, Asian/Pacific Islander, and unknown.

Effect of marital status on CSS {#s3_2}
-------------------------------

Married patients had higher 5-year CSS than unmarried patients (18.7% vs 15.2%) (*P* \< 0.001) (Figure [1](#F1){ref-type="fig"}). Five-year CSS was 18.7% in the married group, 13.9% in the widowed group, 17.9% in the never married group, and 14.4% in the divorced/separated group; a univariate log rank test revealed that CSS differed significantly among all groups (*P* \< 0.001) (Figure [2A](#F2){ref-type="fig"}). Additionally, elderly patients (*P* \< 0.001), black patients (*P* \< 0.001), patients with cholangiocarcinoma (*P* \< 0.001), TNM stage III/IV (*P* \< 0.001), poorly or undifferentiated tumors (*P* \< 0.001), or advanced SEER stage (*P* \< 0.001), and patients who did not undergo surgery (*P* \< 0.001) were at higher risk of poor survival in a univariate analysis (Table [2](#T2){ref-type="table"}).

![Survival curves for married and unmarried biliary tract cancer patients\
χ^2^ = 205.491, *P* \< 0.001.](oncotarget-09-9531-g001){#F1}

![Survival curves for married and unmarried biliary tract cancer patients by stage\
(**A)** All stages: χ^2^ = 23225.337, *P* \< 0.001 (**B)** Stage I: χ^2^ = 42.865, *P* \< 0.001 (**C)** Stage II: χ^2^ = 92.511, *P* \< 0.001 (**D**) Stage III: χ^2^ = 48.252, *P* \< 0.001 (**E**) Stage IV: χ^2^ = 145.801, *P* \< 0.001.](oncotarget-09-9531-g002){#F2}

###### Univariate and multivariate survival analysis of associations between marital status and CSS in SEER database patients

                                Univariate analysis   Multivariate analysis                          
  --------------------- ------- --------------------- ----------------------- ---------------------- ----------
  Sex                           0.480                 0.488                                          NI
   Male                 17.0%                                                                        
   Female               17.2%                                                                        
  Age                           271.377               \< 0.001                                       
   ≤60                  20.9%                                                 Reference              
   \>60                 15.7%                                                 1.388 (1.338--1.441)   \< 0.001
  Race                          39.979                \< 0.001                                       
   White                16.9%                                                 Reference              
   Black                15.2%                                                 1.049 (0.995--1.105)   0.77
   Other^\*^            19.7%                                                 0.896 (0.856--0.938)   \< 0.001
  Tumor site                    1197.390              \< 0.001                                       
   Gallbladder          19.6%                                                 Reference              
   Bile duct            10.5%                                                 0.847 (0.815--0.881)   \< 0.001
   Ampulla of Vater     34.6%                                                 0.569 (0.538--0.602)   \< 0.001
  AJCC 6th TNM stage            4995.646              \< 0.001                                       
   I                    41.4%                                                 Reference              
   II                   21.2%                                                 1.553 (1.446--1.668)   \< 0.001
   III                  13.3%                                                 1.652 (1.525--1.789)   \< 0.001
   IV                   2.0%                                                  2.225 (2.007--2.466)   \< 0.001
   Unknown              8.1%                                                  1.969 (1.816--2.135)   \< 0.001
  Grade                         2945.362              \< 0.001                                       
   I                    41.4%                                                 Reference              
   II                   28.7%                                                 1.275 (1.180--1.377)   \< 0.001
   III                  15.6%                                                 1.761 (1.630--1.902)   \< 0.001
   IV                   17.1%                                                 1.631 (1.372--1.939)   \< 0.001
   Unknown              7.4%                                                  1.461 (1.353--1.577)   \< 0.001
  SEER Stage                    3717.179              \< 0.001                                       
   Localized            34.9%                                                 Reference              
   Regional             21.1%                                                 1.118 (1.047--1.193)   \< 0.001
   Distant              3.3%                                                  1.212 (1.101--1.334)   \< 0.001
   Unknown              7.8%                                                  1.000 (0.917--1.091)   \< 0.001
  Therapy                       5505.595              \< 0.001                                       
   Surgery              33.3%                                                 Reference              
   No surgery           4.1%                                                  2.448 (2.336--2.566)   \< 0.001
   Unknown              9.0%                                                  1.962 (1.687--2.283)   \< 0.001
  Marital Status                284.788               \< 0.001                                       
   Married              18.7%                                                 Reference              
   Widowed              13.9%                                                 1.245 (1.196--1.295)   \< 0.001
   Never married        17.9%                                                 1.142 (1.090--1.197)   \< 0.001
   Divorced/Separated   14.4%                                                 1.135 (1.077--1.196)   \< 0.001

^\*^ Other includes American Indian/Alaska native, Asian/Pacific Islander, and unknown. NI: not included in the multivariate survival analysis.

The following eight variables were identified as independent prognostic factors in multivariate analysis with Cox regression: age (\> 60 years, hazard ratio (HR) 1.388, 95% confidence interval (CI) 1.338--1.441), race (other, HR 0.896, 95% CI 0.856--0.938), tumor site (bile duct, HR 0.847, 95% CI 0.815--0.881; ampulla of Vater, HR 0.569, 95% CI 0.538--0.602), TNM stage (stage II, HR 1.553, 95% CI 1.446--1.668; stage III, HR 1.652, 95% CI 1.525-1.789; stage IV, HR 2.225, 95% CI 2.007--2.466), pathological grade (grade II, HR 1.275, 95% CI 1.180--1.377; grade III, HR 1.761, 95% CI 1.630--1.902; grade IV, HR 1.631, 95% CI 1.372--1.939), SEER stage (regional, HR 1.118, 95% CI 1.047--1.193; distant, HR 1.212, 95% CI 1.101--1.334), therapy (no surgery, HR 2.448, 95% CI 2.336--2.566), and marital status (widowed, HR 1.245, 95% CI 1.196--1.295; never married, HR 1.142, 95% CI 1.090-1.197; divorced/separated, HR 1.135, 95% CI 1.077--1.196).

Subgroup analysis of associations between marital status and survival for different TNM stages {#s3_3}
----------------------------------------------------------------------------------------------

We then analyzed the relationship between marital status and survival at each TNM stage. Marital status was an independent prognostic factor in each tumor stage both in univariate and multivariate analyses (*P* \< 0.05). In addition, widowed patients in the localized stage group had lower survival rates than all other patients. Five-year CSS was reduced by 7.9% in stage I (35.9% vs 43.8%, *P* \< 0.001), 8.9% in stage II (14.6% vs 23.5%, *P* \< 0.001), 5.5% in stage III (8.8% vs 14.3%, *P* \< 0.001), and 1.2% in stage IV (1.2% vs 2.4%, *P* \< 0.001) widowed patients compared to married patients with the same stages. Finally, 5-year CSS rates did not differ between never married and married patients with either regional or distant stage disease (Table [3](#T3){ref-type="table"}, Figure [2B--2D](#F2){ref-type="fig"}).

###### Univariate and multivariate analysis of associations between marital status and CSS for different cancer stages

                                Univariate analysis   Multivariate analysis                          
  --------------------- ------- --------------------- ----------------------- ---------------------- ----------
  **Stage I**                   42.865                \< 0.001                                       
  **Marital status**                                                                                 \< 0.001
   Married              43.8%                                                 Reference              
   Widowed              35.9%                                                 1.369 (1.244--1.506)   \< 0.001
   Never married        42.4%                                                 1.089 (0.962--1.234)   0.178
   Divorced/Separated   39.9%                                                 1.119 (0.971--1.290)   0.119
  **Stage II**                  92.511                \< 0.001                                       
  **Marital status**                                                                                 0.001
   Married              23.5%                                                 Reference              
   Widowed              14.6%                                                 1.522 (1.393--1.664)   \< 0.001
   Never married        23.7%                                                 1.153 (1.037--1.282)   0.009
   Divorced/Separated   17.1%                                                 1.213 (1.080--1.363)   0.001
  **Stage III**                 48.252                \< 0.001                                       
  **Marital status**                                                                                 \< 0.001
   Married              14.3%                                                 Reference              
   Widowed              8.8%                                                  1.504 (1.330--1.701)   \< 0.001
   Never married        18.4%                                                 0.983 (0.850--1.136)   0.813
   Divorced/Separated   8.8%                                                  1.152 (0.996--1.332)   0.056
  **Stage IV**                  145.801               \< 0.001                                       
  **Marital status**                                                                                 \< 0.001
   Married              2.4%                                                  Reference              
   Widowed              1.2%                                                  1.447 (1.355--1.545)   \< 0.001
   Never married        1.2%                                                  1.172 (1.090--1.260)   \< 0.001
   Divorced/Separated   2.0%                                                  1.144 (1.054--1.242)   0.001

Subgroup analysis of associations between marital status and survival for different tumor sites {#s3_4}
-----------------------------------------------------------------------------------------------

We also analyzed the association between marital status and survival for each tumor site. Marital status was again predictive of CSS in univariate and multivariate analyses (*p* \< 0.05). CSS rates were higher in Ampulla of Vater cancer patients than in gallbladder cancer and cholangiocarcinoma patients. Widowed individuals still had the lowest survival rate among all patients (Table [4](#T4){ref-type="table"}).

###### Univariate and multivariate analysis of associations between marital status and CSS for different tumor sites

                                 Univariate analysis   Multivariate analysis                          
  ---------------------- ------- --------------------- ----------------------- ---------------------- ----------
  **Gallbladder**                32.220                \< 0.001                                       
  **Marital status**                                                                                  \< 0.001
   Married               20.4%                                                 Reference              
   Widowed               18.6%                                                 1.195 (1.119--1.276)   \< 0.001
   Never married         19.4%                                                 1.120 (1.033--1.215)   0.006
   Divorced/Separated    18.6%                                                 1.075 (0.981--1.178)   0.122
  **Bile duct**                  257.23                \< 0.001                                       
  **Marital status**                                                                                  \< 0.001
   Married               12.0%                                                 Reference              
   Widowed               7.1%                                                  1.480 (1.406--1.558)   \< 0.001
   Never married         11.4%                                                 1.137 (1.069--1.209)   \< 0.001
   Divorced/Separated    7.1%                                                  1.247 (1.165--1.335)   \< 0.001
  **Ampulla of Vater**           60.189                \< 0.001                                       
  **Marital status**                                                                                  \< 0.001
   Married               37.2%                                                 Reference              
   Widowed               25.7%                                                 1.574 (1.399--1.770)   \< 0.001
   Never married         36.8%                                                 1.075 (0.934--1.239)   0.313
   Divorced/Separated    31.5%                                                 1.108 (0.942--1.305)   0.216

DISCUSSION {#s4}
==========

In this study, we investigated associations between marriage and CSS in a large BTC patient population. We found that married patients have better cause-specific survival outcomes than unmarried patients, which includes widowed and separated/divorced patients and those who never married. This association between being married and better survival persisted even after adjusting for age, race, tumor site, pathology grade, TNM stage, SEER stage, and therapy in multivariable analyses. Moreover, widowed patients had a higher risk of cause-specific death than all other patient groups. Further subgroup analyses based on TNM stage and tumor site confirmed the prognostic value of marital status in BTC patients.

Previous studies have suggested that poorer prognoses in unmarried individuals may be due to delayed diagnosis at more advanced tumor stages in these patients \[[@R13], [@R19], [@R20]\]. However, in our patient population, the percentages of patients at each tumor stage were comparable among the four marriage status subgroups. Moreover, a higher proportion of widowed group patients (27.5%) had localized stage disease compared to married (21.6%), never married (22.6%), and divorced/separated (21.6%) group patients. These results suggest that delayed diagnosis cannot explain the poorer survival outcomes observed in widowed patients.

The exact mechanisms underlying the prognostic impact of marital status in GBC are unclear. Several biological, psychological, and social theories have been postulated to explain this phenomenon. It is well known that a diagnosis of cancer is psychologically distressing for most patients \[[@R21]\]. Because they do not have spouses to share their emotional burdens and contribute to their social support networks, unmarried cancer patients may experience more distress, depression, and anxiety than married patients \[[@R22], [@R23]\]. Additionally, marital status may affect adherence to prescribed treatments. Compared to unmarried patients, married patients are more likely to comply with treatment, to seek treatment at more prestigious centers, and to accept more aggressive treatment, all of which may contribute to better cancer control \[[@R24], [@R25]\].

Physiological changes accompanying stress and depression may worsen cancer outcomes through different mechanisms. For example, decreased psychosocial support and increased psychological stress result in immune dysfunction and contribute to tumor progression and mortality \[[@R26]--[@R28]\]. Furthermore, perceived lack of social support can reduce the activity of natural killer cells \[[@R29]\], resulting in dysregulation of various endocrine hormones, such as cortisol and catecholamines \[[@R26], [@R28]\]. Several studies demonstrate that cortisol and catecholamines can accelerate cancer growth and metastasis via immunosuppressive actions \[[@R30]--[@R32]\]. Cortisol activity has been identified as a prognostic factor in breast and lung cancer \[[@R32], [@R33]\]. Depression and low quality of life are also associated with increased production of VEGF, which may stimulate endothelial cell migration, proliferation, and proteolytic activity \[[@R34]\]. DiMatteo *et al*. found a strong association between depression and medical noncompliance \[[@R35]\], and women with depression who are diagnosed with breast cancer undergo definitive treatment less often and have worse survival outcomes \[[@R36]\].

Some limitations of this study should be considered when interpreting the results. First, the SEER database only provides marital status at the time of diagnosis and does not account for changes in marital status during the follow-up period, which may also influence outcomes. Second, the SEER database lacks details about the quality of marriages (e.g., satisfaction with the relationship, sexual activity), which might be associated with survival in GBC patients. For example, marital distress has long-term immune consequences and enhances the risk of a variety of health problems \[[@R37]\]. Third, and perhaps most important, the SEER database does not provide detailed data regarding chemotherapy, other types of therapy, subsequent therapy, comorbidities, recurrence, or socioeconomic factors.

Despite these potential limitations, our findings demonstrate that marital status is an independent prognostic factor for survival in patients with BTC. Specifically, unmarried patients are at greater risk of cancer-specific mortality. Psychosocial factors may be the main contributors to poorer survival outcomes in unmarried patients; additional social support should therefore be provided for these patients.
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